Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Finasteride increases CD8+ T cells in BPH tissues.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

PDRN is effective and safe for healing wounds and skin issues.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.